SCHEMBL79059

SCHEMBL79059

CC(C)(C)OC(=O)NC1(C#Cc2ccc(OCCCCc3ccccc3)c(C#N)c2)COC(C)(C)OC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
SIGMAR1 Q99720 3/20 0.34
AAK1 Q2M2I8 2/20 0.34
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
PDE4A P27815 3/20 0.34
PDE4B Q07343 3/20 0.34
PDE4C Q08493 3/20 0.34
PDE4D Q08499 3/20 0.34
NAMPT P43490 1/20 0.34
CTSS P25774 2/20 0.34
CTSK P43235 1/20 0.34
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
PGGT1B P53609 1/20 0.33
ABCB1 P08183 3/20 0.33
MTNR1B P49286 1/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL79070 0.98 SIGMAR1 (0.35) ALDH1A1HPGDSIGMAR1AAK1S1PR1
SCHEMBL81934 0.90 AAK1 (0.35) AAK1
SCHEMBL2468973 0.89 ALDH1A1 (0.45) ALDH1A1HPGDAAK1
SCHEMBL2467358 0.89 ALDH1A1 (0.45) ALDH1A1HPGDAAK1
SCHEMBL79759 0.83 S1PR1 (0.37) ALDH1A1HPGDSIGMAR1AAK1S1PR1
SCHEMBL82221 0.80 S1PR1 (0.37) ALDH1A1HPGDSIGMAR1AAK1S1PR1
SCHEMBL81538 0.77 ACACB (0.35) ALDH1A1HPGDCTSSCTSL
SCHEMBL13851976 0.74 SMPD1 (0.33)
SCHEMBL80341 0.74 AAK1 (0.36) AAK1
SCHEMBL4142861 0.73 SMPD1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168944-B1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-11 EP disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
EP-2168944-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C ALDH1A1 646/4885HPGD 2722/4885SIGMAR1 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.